Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 9INDUSTRY 7NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 61Thoracic 57Breast 52Gastrointestinal 17Other solid neoplasm 14Genitourinary 14Head & Neck 13Tumor-Agnostic 9Dermatologic 6Sarcoma 5Lymphoid 5Other hematologic neoplasm 4Endocrine 2Other neoplasm 1CNS 1

Conditions

Thyroid Carcinoma, Anaplastic 2Head and Neck Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 17Specimen Handling 13lutetium Lu 177 dotatate 7gallium Ga 68 dotatate 7Cisplatin 7cabozantinib 6pazopanib 5Sorafenib 5Fluorodeoxyglucose F18 5Everolimus 5Etoposide 4romidepsin 3olaparib 3fluorodopa F 18 3cixutumumab 3X-Rays 3Temozolomide 3Sunitinib 3Radiotherapy 3Nivolumab 3Ipilimumab 3Iodine-131 3CTLA-4 Antigen 32-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3tipifarnib 2belinostat 2aldesleukin 2aflibercept 2Vorinostat 2Trastuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Paclitaxel × Endocrine × Clear all
NCT01236547 2022-07-19

Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer

National Cancer Institute (NCI)

Phase 2 Completed
123 enrolled 24 charts
EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT00004089 2013-07-10

Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer

National Cancer Institute (NCI)

Phase 2 Completed
EndocrineHead & Neck

Head and Neck Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡